Fandosentan

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameFandosentan

Drug Alias NameCI-1034PD-180988PD-1809880016

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEndothelin receptor type A antagonists

TargetsEndothelin receptor type A

Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic Obstructive

ATC CodeN/A